GLYBURIDE Side Effects

6988595-5 | Anaemia, Chronic Myeloid Leukaemia, Gastrointestinal Disorder
on Aug 30, 2010 Female patient from UNITED STATES , 87 years of age, weighting 117.0 lb, was diagnosed with gastric haemorrhage and was treated with Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, chronic myeloid leukaemia, gastrointestinal disorder. Glyburide dosage: . During the same period patient was treated with METFORMIN (View Metformin Review and Metformin Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), IRON (View Iron Review and Iron Label ), PROTONIX (View Protonix Review and Protonix Label ).

6984904-1 | Ataxia, Blood Pressure Increased, Confusional State, Dysarthria, Hyperhidrosis, Hypoglycaemia
Patient was taking Glyburide (View Usage). Patient had the following side effects: ataxia (What is ataxia?), blood pressure increased, confusional state, dysarthria, hyperhidrosis, hypoglycaemia on Aug 30, 2010 from AUSTRALIA Additional patient health information: Male patient , 54 years of age, . Glyburide dosage: X1;po. Patient was hospitalized.

6984714-5 | Confusional State, Fall, Hypoglycaemia
Adverse event was reported on Sep 14, 2010 by a Male patient taking Glyburide (View Usage) (Dosage: 1.25 Mg Tid Po) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 85 years of age, weighting 191.8 lb, After Glyburide was administered, patient had the following side effects: confusional state, fall (What is fall?), hypoglycaemia. Patient was hospitalized.

6971881-2 | Confusional State, Hypoglycaemia, Syncope
on Sep 08, 2010 Male patient from UNITED STATES , 71 years of age, weighting 213.8 lb, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, hypoglycaemia, syncope. Glyburide dosage: 10 Mg Am Po. Patient was hospitalized.


6936406-6 | Blood Glucose Increased, Oesophageal Rupture, Upper Gastrointestinal Haemorrhage, Vomiting
on Aug 17, 2010 Male patient from UNITED STATES , 76 years of age, was treated with Glyburide (View Usage). Patient had the following side effects: blood glucose increased, oesophageal rupture, upper gastrointestinal haemorrhage, vomiting. Glyburide dosage: . During the same period patient was treated with JANUVIA (View Januvia Review and Januvia Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

6935982-7 | Dizziness, Hypoglycaemia, Syncope
Patient was taking Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: dizziness (What is dizziness?), hypoglycaemia, syncope on Aug 19, 2010 from UNITED STATES Additional patient health information: Male patient , 69 years of age, weighting 169.8 lb, was diagnosed with type 2 diabetes mellitus and. Glyburide dosage: 2.5 Mg Bid Po. Patient was hospitalized.

6926413-1 | Fall, Hypoglycaemia, Mental Status Changes
Adverse event was reported on Aug 16, 2010 by a Male patient taking Glyburide (View Usage) (Dosage: 5 Mg Bid Po) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 64 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: fall (What is fall?), hypoglycaemia, mental status changes. Patient was hospitalized.

6915246-8 | Condition Aggravated, Diabetes Mellitus, Injury, Pancreatic Disorder
on Aug 06, 2010 Male patient from UNITED STATES , 62 years of age, weighting 180.0 lb, was diagnosed with glucose tolerance impaired and was treated with Glyburide (View Usage). Patient had the following side effects: condition aggravated, diabetes mellitus, injury, pancreatic disorder. Glyburide dosage: 2.5 Mg 2 Per Day Po. Patient was hospitalized and became disabled.

6880319-5 | Deafness, Deafness Neurosensory
on Jun 21, 2010 Female patient from UNITED STATES , 73 years of age, weighting 130.1 lb, was diagnosed with diabetes mellitus, blood glucose increased and was treated with Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: deafness, deafness neurosensory. Glyburide dosage: . During the same period patient was treated with METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), LISINOPRIL (Taking For Many Years) (View Lisinopril Review and Lisinopril Label ), COD LIVER OIL (View Cod Liver Oil Review and Cod Liver Oil Label ).

6861948-1 | Hypoglycaemia, Hypophagia
Patient was taking Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, hypophagia on Jul 20, 2010 from UNITED STATES Additional patient health information: Male patient , 67 years of age, weighting 220.9 lb, was diagnosed with type 2 diabetes mellitus and. Glyburide dosage: 5 Mg Bid Po. Patient was hospitalized.

6861089-3 | Blood Bicarbonate Decreased, Blood Ph Decreased, Blood Pressure Immeasurable, Cardiac Arrest, Cardio-respiratory Arrest, Hypoglycaemic Coma, Lactic Acidosis, Mydriasis
Adverse event was reported on Jul 12, 2010 by a Female patient taking Glyburide (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: FRANCE , 54 years of age, Patient had the following side effects: blood bicarbonate decreased, blood ph decreased, blood pressure immeasurable, cardiac arrest (What is cardiac arrest?), cardio-respiratory arrest, hypoglycaemic coma, lactic acidosis, mydriasis. During the same period patient was treated with ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ). Patient was hospitalized.

6810775-X | Immune System Disorder, Pain
on Mar 12, 2008 Male patient from UNITED STATES , weighting 204.0 lb, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: immune system disorder, pain (What is pain?). Glyburide dosage: .

6810672-X | Abdominal Pain Upper, Blister, Blood Glucose Increased, Blood Triglycerides Increased, Genital Rash
on May 11, 2007 Male patient from UNITED STATES , 41 years of age, was diagnosed with hyperglycaemia, hermaphroditism, hypertriglyceridaemia and was treated with Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, blister, blood glucose increased, blood triglycerides increased, genital rash. Glyburide dosage: . During the same period patient was treated with TESTOSTERONE (View Testosterone Review and Testosterone Label ), TRICOR (View Tricor Review and Tricor Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NAPROSYN (View Naprosyn Review and Naprosyn Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), BACLOFEN (View Baclofen Review and Baclofen Label ).

6785221-5 | Dizziness, Fall, Hypoglycaemia, Syncope
Patient was taking Glyburide (View Usage). Patient had the following side effects: dizziness (What is dizziness?), fall (What is fall?), hypoglycaemia, syncope on Jun 22, 2010 from UNITED STATES Additional patient health information: Male patient , 61 years of age, weighting 149.9 lb, was diagnosed with diabetes mellitus and. Glyburide dosage: 5 Mg Bid Po. During the same period patient was treated with INSULIN (5 Units Bid Sq) (View Insulin Review and Insulin Label ).

6773992-3 | Hypoglycaemia, Mental Status Changes
Adverse event was reported on Jun 16, 2010 by a Male patient taking Glyburide (View Usage) (Dosage: 5 Mg Every Day Po) was diagnosed with type 1 diabetes mellitus and. Location: UNITED STATES , 77 years of age, weighting 269.4 lb, After Glyburide was administered, patient had the following side effects: hypoglycaemia, mental status changes. Patient was hospitalized.

6767255-X | Fall, Hypoglycaemia
on Jun 11, 2010 Male patient from UNITED STATES , 88 years of age, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), hypoglycaemia. Glyburide dosage: 2.5 Mg Every Day Po. Patient was hospitalized.

6736475-2 | Pulmonary Embolism
on May 05, 2010 Male patient from UNITED STATES , 67 years of age, was diagnosed with pain (What is pain?) and was treated with Glyburide (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Glyburide dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ). Patient was hospitalized.

6731222-2 | Diabetes Mellitus Inadequate Control, Product Measured Potency Issue, Product Substitution Issue
Patient was taking Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: diabetes mellitus inadequate control, product measured potency issue, product substitution issue on May 17, 2010 from UNITED STATES Additional patient health information: Male patient , 65 years of age, weighting 160.0 lb, was diagnosed with type 2 diabetes mellitus and. Glyburide dosage: 5 Mgm Bid Po.

6706150-9 | Myocardial Infarction
Adverse event was reported on Apr 25, 2010 by a Female patient taking Glyburide (View Usage) (Dosage: ) . Location: UNITED STATES , 68 years of age, Patient experienced the following unwanted or unexpected effects: myocardial infarction. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6681288-3 | Blood Glucose Increased, Pneumonia
on Mar 12, 2010 Male patient from UNITED STATES , 74 years of age, was treated with Glyburide (View Usage). Patient had the following side effects: blood glucose increased, pneumonia (What is pneumonia?). Glyburide dosage: . During the same period patient was treated with JANUVIA (View Januvia Review and Januvia Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6647481-0 | Hypoglycaemia, Oxygen Saturation Decreased, Supraventricular Tachycardia, Unresponsive To Stimuli
on Mar 23, 2010 Male patient from UNITED STATES , 77 years of age, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: hypoglycaemia, oxygen saturation decreased, supraventricular tachycardia, unresponsive to stimuli. Glyburide dosage: 10 Mg Bid Po. Patient was hospitalized.

6644690-1 | Hypoglycaemia
Patient was taking Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia on Mar 18, 2010 from UNITED STATES Additional patient health information: Male patient , 79 years of age, weighting 260.1 lb, was diagnosed with diabetes mellitus and. Glyburide dosage: 2.5 Mg Am Po. During the same period patient was treated with CIPROFLOXACIN (500 Mg Bid Po) (View Ciprofloxacin Review and Ciprofloxacin Label ). Patient was hospitalized.

6641454-X | Hypoglycaemia, Hypophagia
Adverse event was reported on Mar 17, 2010 by a Male patient taking Glyburide (View Usage) (Dosage: 7.5 Mg Every Day Po) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 77 years of age, Patient had the following side effects: hypoglycaemia, hypophagia. Patient was hospitalized.

6641356-9 | Blood Glucose Increased, Product Substitution Issue
on Mar 17, 2010 Female patient from UNITED STATES , 68 years of age, weighting 174.0 lb, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: blood glucose increased, product substitution issue. Glyburide dosage: 5mg 2 Tid Po.

6631756-5 | Myocardial Infarction
on Mar 05, 2010 Female patient from UNITED STATES , 71 years of age, was treated with Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Glyburide dosage: 1 Tablet Twice Daily. During the same period patient was treated with METFORMIN (1 Tablet Daily) (View Metformin Review and Metformin Label ). Patient was hospitalized.

6607965-8 | Rash, Urticaria
Patient was taking Glyburide (View Usage). Patient had the following side effects: rash (What is rash?), urticaria on Feb 26, 2010 from UNITED STATES Additional patient health information: Male patient , 89 years of age, weighting 209.4 lb, was diagnosed with diabetes mellitus and. Glyburide dosage: 2.5 Mg Bid Po. Patient was hospitalized.

6594513-4 | Convulsion, Hypoglycaemia
Adverse event was reported on Feb 18, 2010 by a Male patient taking Glyburide (View Usage) (Dosage: 10 Mg Bid Po) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 63 years of age, After Glyburide was administered, patient had the following side effects: convulsion, hypoglycaemia. Patient was hospitalized.

6568393-7 | Glaucoma, Renal Failure Chronic
on Jan 25, 2010 Female patient from UNITED STATES , 61 years of age, was treated with Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: glaucoma (What is glaucoma?), renal failure chronic. Glyburide dosage: . During the same period patient was treated with LANTUS (Dose:11 Unit(s)) (View Lantus Review and Lantus Label ), OPTICLICK (View Opticlick Review and Opticlick Label ).

6565985-6 | Hypoglycaemia, Renal Failure Acute, Syncope
on Jan 29, 2010 Female patient from UNITED STATES , 78 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Glyburide (View Usage). Patient had the following side effects: hypoglycaemia, renal failure acute, syncope. Glyburide dosage: 10 Mg Bid Po. Patient was hospitalized.

6546063-9 | Incorrect Dose Administered
Patient was taking Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: incorrect dose administered on Jan 04, 2010 from UNITED STATES Additional patient health information: Female patient , 90 years of age, . Glyburide dosage: Oral. During the same period patient was treated with DILTIAZEM (Oral) (View Diltiazem Review and Diltiazem Label ), HYDRALAZINE (View Hydralazine Review and Hydralazine Label ), TENORMIN (View Tenormin Review and Tenormin Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), METOLAZONE (View Metolazone Review and Metolazone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

6546048-2 | Completed Suicide
Adverse event was reported on Jan 04, 2010 by a Male patient taking Glyburide (View Usage) (Dosage: Oral) . Location: UNITED STATES , 67 years of age, Patient experienced the following unwanted or unexpected effects: completed suicide. During the same period patient was treated with METFORMIN HCL (Oral) (View Metformin Hcl Review and Metformin Hcl Label ), PROCHLORPERAZINE (Oral) (View Prochlorperazine Review and Prochlorperazine Label ), DIPHENHYDRAMINE HCL (Oral) (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ).

6545921-9 | Hypoglycaemia
on Jan 21, 2010 Male patient from UNITED STATES , 69 years of age, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). Patient had the following side effects: hypoglycaemia. Glyburide dosage: 5 Mg. Patient was hospitalized.

6540401-9 | Blood Creatinine Abnormal, Cardiac Failure Congestive, Condition Aggravated, Failure To Thrive, Hypoglycaemia, Pneumonia Aspiration
on Jan 05, 2010 Male patient from UNITED STATES , 78 years of age, was treated with Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: blood creatinine abnormal, cardiac failure congestive, condition aggravated, failure to thrive, hypoglycaemia, pneumonia aspiration. Glyburide dosage: . Patient was hospitalized.

6505993-4 | Hypoglycaemia, Syncope
Patient was taking Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, syncope on Dec 17, 2009 from UNITED STATES Additional patient health information: Male patient , 66 years of age, weighting 228.0 lb, was diagnosed with type 2 diabetes mellitus and. Glyburide dosage: 10 Mg Bid Po. Patient was hospitalized.

6489870-3 | Product Lot Number Issue, Product Substitution Issue
Adverse event was reported on Dec 10, 2009 by a Female patient taking Glyburide (View Usage) (Dosage: 2.5 Mg 4 Times A Day) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , weighting 180.3 lb, Patient had the following side effects: product lot number issue, product substitution issue.

6453974-1 | Blood Glucose Increased, Cardiac Disorder
on Nov 02, 2009 Male patient from UNITED STATES , 63 years of age, weighting 241.0 lb, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: blood glucose increased, cardiac disorder. Glyburide dosage: 3mg, Bid,. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), SPIRONLACTONE (View Spironlactone Review and Spironlactone Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CRESTOR (View Crestor Review and Crestor Label ), CILOSTAZOL (View Cilostazol Review and Cilostazol Label ).

6442461-2 | Hepatitis Acute
on Oct 27, 2009 Male patient from CHINA , 68 years of age, was treated with Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis acute. Glyburide dosage: .

6434802-7 | Depressed Level Of Consciousness, Eating Disorder, Hypoglycaemia, Treatment Noncompliance, Upper Respiratory Tract Infection
Patient was taking Glyburide (View Usage). Patient had the following side effects: depressed level of consciousness, eating disorder (What is eating disorder?), hypoglycaemia, treatment noncompliance, upper respiratory tract infection on Nov 09, 2009 from UNITED STATES Additional patient health information: Female patient , 84 years of age, was diagnosed with diabetes mellitus and. Glyburide dosage: 10 Mg Bid Po. During the same period patient was treated with CELEXA (View Celexa Review and Celexa Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DIOVAN (View Diovan Review and Diovan Label ), EVISTA (View Evista Review and Evista Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), VYTORIN (View Vytorin Review and Vytorin Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), VITAMIN E (View Vitamin E Review and Vitamin E Label ). Patient was hospitalized.

6428586-6 | Hypoglycaemia
Adverse event was reported on Nov 04, 2009 by a Male patient taking Glyburide (View Usage) (Dosage: 5 Mg Bid Po) was diagnosed with diabetes mellitus and. Location: UNITED STATES , 77 years of age, After Glyburide was administered, patient had the following side effects: hypoglycaemia. Patient was hospitalized.

6425305-4 | Hypoglycaemia
on Nov 02, 2009 Male patient from UNITED STATES , 75 years of age, weighting 143.3 lb, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia. Glyburide dosage: 5 Mg Bid Po. Patient was hospitalized.

6423790-5 | Hypoglycaemia, Unresponsive To Stimuli
on Oct 30, 2009 Male patient from UNITED STATES , 61 years of age, weighting 394.8 lb, was diagnosed with diabetes mellitus and was treated with Glyburide (View Usage). Patient had the following side effects: hypoglycaemia, unresponsive to stimuli. Glyburide dosage: 2.5 Mg Every Day Po. During the same period patient was treated with METFORMIN HCL (850 Mg Bid Po) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6419741-X |
Patient was taking Glyburide (View Usage). on Oct 16, 2009 from UNITED STATES Additional patient health information: Male patient , 58 years of age, . Glyburide dosage: . During the same period patient was treated with PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ), RIBAVIRIN (View Ribavirin Review and Ribavirin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ORAL ANTIDIABETICS (View Oral Antidiabetics Review and Oral Antidiabetics Label ), NORVASC (View Norvasc Review and Norvasc Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FLEXERIL (View Flexeril Review and Flexeril Label ).

6414675-9 | Dehydration, Diabetic Complication, Metastases To Spine, Prostate Cancer, Renal Failure
Adverse event was reported on Oct 14, 2009 by a Male patient taking Glyburide (View Usage) (Dosage: 5 Mg Daily, Oral) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 76 years of age, weighting 130.0 lb, Patient experienced the following unwanted or unexpected effects: dehydration, diabetic complication, metastases to spine, prostate cancer (What is prostate cancer?), renal failure. During the same period patient was treated with METFORMIN (ZYDUS PHARMACEUTICALS) (Oral) (View Metformin (zydus Pharmaceuticals) Review and Metformin (zydus Pharmaceuticals) Label ).

6412276-X | Circulatory Collapse, Constipation, Large Intestinal Obstruction, Multi-organ Failure, Myoclonus, Salivary Hypersecretion
on Oct 14, 2009 Male patient from CANADA , 63 years of age, was diagnosed with hypothyroidism, schizophrenia, constipation (What is constipation?) and was treated with Glyburide (View Usage). Patient had the following side effects: circulatory collapse, constipation (What is constipation?), large intestinal obstruction, multi-organ failure, myoclonus, salivary hypersecretion. Glyburide dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CLOZAPINE (View Clozapine Review and Clozapine Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ). Patient was hospitalized.

6407742-7 |
on Oct 11, 2009 Male patient from UNITED STATES , 58 years of age, was treated with Glyburide (View Usage). . Glyburide dosage: . During the same period patient was treated with PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ), RIBAVIRIN (View Ribavirin Review and Ribavirin Label ), METFORMIN (View Metformin Review and Metformin Label ).

6386364-0 | Fatigue
Patient was taking Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue on Sep 30, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 244.0 lb, . Glyburide dosage: .

6383606-2 | Hypoglycaemia
Adverse event was reported on Sep 29, 2009 by a Male patient taking Glyburide (View Usage) (Dosage: 5 Mg Every Day Po) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , 72 years of age, weighting 188.9 lb, Patient had the following side effects: hypoglycaemia. During the same period patient was treated with INSULIN (4-12 Units Prn Sq) (View Insulin Review and Insulin Label ). Patient was hospitalized.

6381911-7 | Diabetes Mellitus, Hypoglycaemia
on Sep 15, 2009 Female patient from UNITED STATES , 61 years of age, was treated with Glyburide (View Usage). After Glyburide was administered, patient had the following side effects: diabetes mellitus, hypoglycaemia. Glyburide dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), SIROLIMUS (View Sirolimus Review and Sirolimus Label ), THYMOGLOBULIN (View Thymoglobulin Review and Thymoglobulin Label ).

6377329-3 | Asthenia, Creatinine Renal Clearance Decreased, Loss Of Consciousness, Syncope, Tremor
on Sep 23, 2009 Female patient from UNITED STATES , 65 years of age, was diagnosed with diabetes mellitus, type 1 diabetes mellitus and was treated with Glyburide (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, creatinine renal clearance decreased, loss of consciousness, syncope, tremor. Glyburide dosage: 5 Mg Po Daily. During the same period patient was treated with LANTUS (160 Units Sq Bid) (View Lantus Review and Lantus Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), MORPHINE (View Morphine Review and Morphine Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), DULOXETINE (View Duloxetine Review and Duloxetine Label ).

6376318-2 | Hypoglycaemia
Patient was taking Glyburide (View Usage). Patient had the following side effects: hypoglycaemia on Sep 22, 2009 from UNITED STATES Additional patient health information: Male patient , 83 years of age, weighting 154.8 lb, was diagnosed with type 2 diabetes mellitus and. Glyburide dosage: 5 Mg Every Day Po. Patient was hospitalized.